13.16
0.10 (0.77%)
| Penutupan Terdahulu | 13.06 |
| Buka | 13.18 |
| Jumlah Dagangan | 566,765 |
| Purata Dagangan (3B) | 1,096,412 |
| Modal Pasaran | 1,025,305,984 |
| Harga / Pendapatan (P/E Ke hadapan) | 5.52 |
| Harga / Jualan (P/S) | 0.630 |
| Harga / Buku (P/B) | 1.01 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 30 Oct 2025 |
| Margin Keuntungan | -1.78% |
| Margin Operasi (TTM) | 8.23% |
| EPS Cair (TTM) | -0.380 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 3.70% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -2.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 132.59% |
| Nisbah Semasa (MRQ) | 1.21 |
| Aliran Tunai Operasi (OCF TTM) | 102.37 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 35.55 M |
| Pulangan Atas Aset (ROA TTM) | 2.66% |
| Pulangan Atas Ekuiti (ROE TTM) | -1.86% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | Integra LifeSciences Holdings C | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | -5.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 2.0 |
| Purata | -0.63 |
|
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 14.23% |
| % Dimiliki oleh Institusi | 96.47% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 13.00 (JP Morgan, -1.22%) | Jual |
| 13.00 (Truist Securities, -1.22%) | Pegang | |
| Median | 13.00 (-1.22%) | |
| Rendah | 11.00 (Citigroup, -16.41%) | Jual |
| Purata | 12.33 (-6.31%) | |
| Jumlah | 1 Pegang, 2 Jual | |
| Harga Purata @ Panggilan | 11.84 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Truist Securities | 03 Nov 2025 | 13.00 (-1.22%) | Pegang | 11.49 |
| 15 Oct 2025 | 15.00 (13.98%) | Pegang | 14.23 | |
| Citigroup | 31 Oct 2025 | 11.00 (-16.41%) | Jual | 12.01 |
| 07 Oct 2025 | 12.00 (-8.81%) | Jual | 14.43 | |
| JP Morgan | 31 Oct 2025 | 13.00 (-1.22%) | Jual | 12.01 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 01 Dec 2025 | Pengumuman | Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference |
| 25 Nov 2025 | Pengumuman | Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access |
| 11 Nov 2025 | Pengumuman | Integra LifeSciences Receives FDA 510(k) Clearance for Use of the CUSA® Clarity Ultrasonic Surgical Aspirator System for Cardiac Surgeries |
| 30 Oct 2025 | Pengumuman | Integra LifeSciences Reports Third Quarter 2025 Financial Results |
| 15 Oct 2025 | Pengumuman | Integra LifeSciences to Host Third Quarter 2025 Financial Results Conference Call on October 30, 2025 |
| 08 Oct 2025 | Pengumuman | Integra LifeSciences to Spotlight Neurosurgical Product Portfolio at the Congress of Neurological Surgeons (CNS) Annual Meeting |
| 22 Sep 2025 | Pengumuman | Integra LifeSciences Strengthens Leadership with Appointment of New Chief Medical Officer |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |